G01N 2333/70542
Cd106
G01N2333/70542 (Cd106) appears on 8 US grants and 25 published applications in this corpus.
Search patents in G01N- Granted patents
- 8
- Published applications
- 25
- Assignees
- 21
- Inventors
- 72
- Latest grant
- 2 Jan 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 2 | 2 |
| 2015 | 0 | 6 |
| 2016 | 0 | 0 |
| 2017 | 2 | 2 |
| 2018 | 1 | 4 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 2 | 2 |
| 2022 | 0 | 0 |
| 2023 | 0 | 2 |
| 2024 | 1 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Assay method for the detection of VCAM-1 and alpha-2-macroglobulin in blood2 Jan 2024US 11,860,170 B2Procisedx Inc.
- Endothelial cell derived exosomes and uses thereof7 Dec 2021US 11,193,943 B2
- Biomarker-based methods for aiding the diagnosis of stroke9 Feb 2021US 10,914,745 B2Randox Laboratories Limited
- Antibodies against CD106 (VCAM-1)7 Aug 2018US 10,040,854 B2Oxford University Innovation Limited
- Biomarker panel for assessment of mucosal healing5 Dec 2017US 9,835,632 B2Nestec S. A.
- Methods for diagnosing advanced liver fibrosis or liver cirrhosis10 Sep 2026US 2026/0266842 A1Genfit
- Methods for diagnosing advanced liver fibrosis or liver cirrhosis10 Sep 2026US 2026/0266843 A1Genfit
- Assay method for the detection of vcam-1 and alpha-2-macroglobulin in blood11 Jan 2024US 2024/0012007 A9Procisedx Inc.
- Assay method for the detection of vcam-1 and alpha-2-macroglobulin in blood4 May 2023US 2023/0139053 A1Procisedx Inc.
- Csf-based prognostic biomarkers in alzheimer's disease and methods of use thereof5 Jan 2023US 2023/0003744 A1Emory University
Most cited
By later US patents
- Methods for improving inflammatory bowel disease diagnosis9US 8,715,943 B2Nestec S. A. · 2014
- Human recombinant monoclonal antibody that specifically binds to VCAM-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells2US 8,623,368 B2Hanwha Chemical Corporation · 2014
- Compositions and methods for diagnosing and monitoring ovarian cancer progression and treatment2US 9,606,123 B2University of Virginia Patent Foundation · 2017